U.S. Histology And Cytology Market Size & Outlook, 2025-2030
Related Markets
U.S. histology and cytology market highlights
- The U.S. histology and cytology market generated a revenue of USD 6,859.6 million in 2024 and is expected to reach USD 15,409.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 14.4% from 2025 to 2030.
- In terms of segment, cytology was the largest revenue generating type in 2024.
- Cytology is the most lucrative type segment registering the fastest growth during the forecast period.
Histology and cytology market data book summary
| Market revenue in 2024 | USD 6,859.6 million |
| Market revenue in 2030 | USD 15,409.5 million |
| Growth rate | 14.4% (CAGR from 2025 to 2030) |
| Largest segment | Cytology |
| Fastest growing segment | Cytology |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Histology, Cytology |
| Key market players worldwide | Hologic Inc, BD, Abbott Laboratories, Merck KGaA, Roche Holding AG, Thermo Fisher Scientific Inc, Becton Dickinson & Co, Danaher Corp, Sysmex Corp, Koninklijke Philips NV |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.5% of the global histology and cytology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. histology and cytology market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 2,118.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Histology And Cytology Market Scope
Histology And Cytology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
U.S. histology and cytology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to histology and cytology market will help companies and investors design strategic landscapes.
Cytology was the largest segment with a revenue share of 72.46% in 2024. Horizon Databook has segmented the U.S. histology and cytology market based on histology, cytology covering the revenue growth of each sub-segment from 2018 to 2030.
Human Papilloma Virus (HPV) infection is the most common sexually transmitted disease in the U.S. Presence of organized and quality-assured cytology screening programs in the U.S. has increased the demand for these services. These programs are of high quality and cover a large percentage of the population. Operating players are also introducing new products to meet the growing demand.
For instance, in August 2021 , BD introduced BD COR PX/GX System, a fully automated high-throughput diagnostic system, to expand its offerings in the U.S. market. This system is, initially, available with the company’s Onclarity HPV Assay with extended genotyping. Over the past 30 years, periodic cervical cancer cytology screening has led to a 50% reduction in incidence of cervical cancer in the U.S. Efficient sample collection and detection of cells has increased the effectivity of programs.
Women undergoing regular Pap tests have a better chance of detecting cervical pre-cancer before it progresses to cancer. However, amidst the ongoing COVID-19 pandemic, CDC’s National Breast and Cervical Cancer Early Detection Program has witnessed 84% decline in cervical cancer tests and 87% decline in breast cancer test in April 2020.
Reasons to subscribe to U.S. histology and cytology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. histology and cytology market databook
-
Our clientele includes a mix of histology and cytology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. histology and cytology market , including forecasts for subscribers. This country databook contains high-level insights into U.S. histology and cytology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. histology and cytology market size, by cytology, 2018-2030 (US$M)
U.S. Histology And Cytology Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
